Targeted therapy drugs have different side effects than standard or traditional chemotherapy. Some targeted drugs have very few side effects, and others can cause more or more serious problems. There are many different types of targeted drugs, and their side effects depend largely on the type of drug that's given and what it targets.
Most side effects go away over time after treatment ends and the healthy cells recover. The time it takes to get over some side effects varies from person to person. It depends on many factors, including your overall health and the drugs you were given.
Because many targeted drugs are still quite new, it’s hard to say how long you can expect side effects to last. We do know that some of the side effects from standard or traditional chemo drugs can last a lifetime, such as when the drug causes long-term damage to the heart, lungs, kidneys, or reproductive organs. In many cases we still don’t know if targeted therapy drugs cause these kinds of long-term changes.
Many targeted therapy drugs cause a rash or other skin changes. These skin problems usually develop slowly over days to weeks after your treatment starts. They are not signs of a drug allergy.
In contrast, allergic reactions are different because they tend to start suddenly, usually within minutes to hours after taking the drug. They may include hives (raised skin welts that often go away in a day or so) and intense itching. An allergic reaction often includes other serious symptoms such as trouble breathing, dizziness, tightness in the throat or chest, or swelling of the lips or tongue. If you have these kinds of symptoms, get emergency help and call your doctor right away.
Skin changes are caused by the way some targeted therapy drugs work. For instance, some targeted drugs attack the epidermal growth factor receptor (EGFR) protein, which tells the cancer cells to grow and divide. These are called EGFR inhibitors, and examples are cetuximab (Erbitux), panitumumab (Vectibix), and erlotinib (Tarceva). The problem is that normal skin cells also have a lot of EGFR, so drugs that target or block EGFR can affect skin cells, too. They turn off the signal for skin cells to grow normally and make it harder for them to retain moisture.
Drugs called angiogenesis inhibitors often target vascular endothelial growth factor (VEGF) proteins. Bevacizumab (Avastin) is one of these drugs. The VEGF proteins help tumors build and keep a blood supply, but they also seem to be important to the very small blood vessels in the hands and feet. Blocking these proteins leads to damage in these tiny blood vessels which can cause hand-foot syndrome (described later).
Changes in how your skin feels: Your skin may start to feel like it’s sunburned, before any redness or rash shows up. Even though it doesn’t look different, the sensation can be disturbing. You may notice this change on your face as early as the first week of treatment.
Photosensitivity: Your skin will likely become much more sensitive to light and more easily damaged by UV rays during treatment. It may very easily be burned and blister, even after very little sun exposure or exposure to sun coming through windows.
Rash: This is the most common skin change from targeted drugs. The risk of getting a rash and how bad it gets depends on the type and dose of the targeted drug. In most people, the rash is mild. It often looks like acne and shows up on the scalp, face, neck, chest, and upper back. In severe cases it can affect other parts of the body.
The rash most often starts as skin redness and swelling. It’s often worst within the first few weeks of treatment. By about a month into treatment, the skin usually crusts and gets very dry and red. In the weeks after that, round, flat or raised red spots and pimples with pus in the center often appear. In some people this can lead to skin infections. The rash can itch, burn, or sting, and may be painful. It may get better on its own or stay about the same during the rest of treatment, but it should go away completely about a month after treatment is stopped.
The rash can be very distressing and make a person feel self-conscious around others. There are some medications that your doctor can try to make you feel better while you have the rash. Prevention and treatment of rashes are discussed later.
Dry skin: This is very common for many targeted therapy drugs. It can start within the first few weeks, but nearly everyone getting targeted therapy has dry skin after 6 months of treatment. The skin can become very dry, brittle, itchy, and scaly and may even crack open – especially on the hands and feet. Cracking can happen by itself, but it tends to be worse when there’s also a rash.
Itching: Many skin changes, like rash or dryness, can cause itching.
Red, sore cuticles (the areas around the nails): Some targeted drugs can cause swollen, red, and painful sores around the fingernails and toenails. (This can look a lot like an infection or an ingrown nail.) This most often happens to the big toes and thumbs. These sores may become infected. Nails may also become brittle and grow more slowly.
Hand-foot syndrome: Hand-foot syndrome (HFS) has been linked to many cancer treatment drugs, including some targeted therapies. The cause of this syndrome isn’t known for sure. It may have to do with damage to the tiny blood vessels in the hands and feet, or with the drugs themselves leaking out of the blood vessels and causing damage.
HFS usually starts during the first two to six weeks of treatment. Painful sensitivity, tingling, or numbness in the hands and feet are the earliest symptoms of HFS. Then, the palms of the hands and the soles of the feet become red and swollen. The redness looks a lot like sunburn and may blister. In severe cases, the blisters can open up and become sores. The affected skin also can become dry, peel, and crack.
HFS can be painful and can affect your ability to walk and do your normal activities. If it becomes severe, pain medicines may be needed. Let your doctor know if you’re having HFS symptoms – even if they’re mild. Treating HFS early can help keep it from getting worse. Like the other skin changes, it can be treated, and there are things you can do to try to prevent it.
Changes in hair growth: Some targeted drugs can cause the hair on your head to become thin, dry and brittle, or even curly. Long-term use may lead to bald patches or complete loss of scalp hair. Facial hair may grow faster than usual, including longer, thicker, curly eyebrows and eyelashes that may need to be trimmed. But in some men, facial hair growth slows down. Eyebrows may thin out as well. These changes usually don’t happen right away, but you may notice them later as treatment goes on.
Some people notice sores on their scalp and on other hairy areas. Scars caused by these sores may keep your hair from growing back after treatment.
Changes in hair or skin color: Some targeted drugs can turn the skin or hair a yellowish color during treatment. In a few people, hair and/or skin gets darker. This tends to go away once treatment ends.
Changes in and around the eyes: The eyes may burn, and become dry or red. In some people, the eyelids get red, tender, and swollen, and the lashes may become crusty. Sometimes the eyelids may turn inward or outward. Distorted eyelids or prolonged dryness can damage the outer part of the eye (the cornea). Talk with your doctor or nurse about managing these changes to avoid injury, pain, or infection.
There are things you can do to help prevent skin changes or at least try to keep them under control. Your doctor may ask you to start doing these things as soon as targeted treatment starts – before you have skin problems.
Starting good skin care before you have side effects may help to minimize the problems You may be asked to:
Ask your doctor or nurse if there are other things you can do to help lower your chance of skin problems.
It’s very important to tell your cancer care team right away if you notice any rashes or skin changes. Left untreated, rashes can get worse and lead to infections, which might then lead to delaying or even stopping treatment.
Don’t treat your skin with over-the-counter medicines or stop taking your targeted drug without talking to your doctor first. Your doctor may give you a skin cream or a medicine to take by mouth to treat the skin.
Be sure to let your doctor or nurse know if:
Your doctor may tell you to avoid direct exposure to sunlight when possible. Even after treatment is over, you may find that you’re more sensitive to sunlight than before.
If you have skin changes, your doctor will need to check your skin fairly often to figure out the problem, the best course of action, and whether treatment is helping. You’ll probably need extra doctor visits while the problem is being brought under control.
Mild changes: Patients with mild skin changes may not need treatment. These changes include rashes that are only in a limited area, that are not causing any distress, and are not infected. Heavy skin creams or ointments that contain no alcohol, perfume, or dye can sometimes help with dryness. Be sure to talk with your cancer care team before using anything on your skin.
The doctor may prescribe a mild corticosteroid cream or antibiotic gel to put on the rash.
If your eyelids are crusty or swollen, careful cleansing and clean, warm, wet cloths laid over your closed eyes may help.
For mild skin problems, the dose of the targeted drug usually does not need to be changed. You’ll be watched closely to see if the rash gets better or worse.
Moderate changes: These include a rash over a larger area of the body or skin changes causing mild distress from itching or soreness, but with no signs of infection. The skin may be treated with a prescription cream or gel. The doctor may also prescribe an antibiotic you take by mouth. Drops or ointments may be prescribed to help with eye problems.
The dose of the targeted therapy drug usually does not need to be changed for moderate skin problems. Still, you will be watched closely to see if the rash gets better or worse.
Severe changes: These are bad rashes that cover a lot of skin, cause itching and soreness that affect your quality of life (such as sleep problems or pain), and are likely to get infected. Treatment is much like that used for moderate changes, including creams or gels, as well as an antibiotic that’s taken by mouth. Along with this, a course of corticosteroid pills is often given.
The targeted therapy drug dose often needs to be reduced when a person has severe skin changes. Expect to see your doctor often during this time. If the rash doesn’t get better within about 2 weeks, the targeted drug is often stopped until the skin changes improve. It may then be re-started with continued skin care.
Steroids that are spread on the skin in the form of creams, ointments, or gels can help many skin problems. But it’s important to know that using steroid creams for too long can actually cause other skin problems, and can make you more likely to get a skin infection. For this reason, only use steroid creams (even those that don’t require a prescription) as directed by your doctor.
Some of the other common and serious side effects caused by targeted therapy drugs are listed here. This is not a complete list, as each targeted drug can have different side effects.
Some targeted drugs, especially those called angiogenesis inhibitors, can raise your blood pressure. There isn’t really anything you can do to prevent this, but your doctor will watch your blood pressure closely if you’re getting a drug that can cause this side effect. Some people need medicine to bring their blood pressure down to safe levels during treatment. They should stay on this medicine until their doctor tells them it can be stopped.
Some targeted therapy drugs interfere with new blood vessel growth. This can lead to problems with bruising and bleeding. These problems are not common and do not happen to everyone. But it can help to be aware of them because there’s no known way to prevent them.
Bleeding, such as from the stomach and intestines, can be severe and even life threatening. Tell your doctor if you throw up blood or material that looks like coffee grounds, or if you notice dark or black stools or bright red blood in your stool. These can be signs of bleeding in the stomach or intestines.
Some drugs can also cause blood clots in the lungs and legs, as well as heart attacks and strokes. Let your doctor know if you have problems with sudden swelling, pain, or tenderness in the arm or leg. If you have chest pain, sudden shortness of breath, vision problems, weakness, seizures, or trouble speaking, get emergency help. These can be symptoms of serious problems caused by blood clots.
By blocking new blood vessel growth, some of these drugs interfere with wound healing. This can lead to old wounds (cuts) opening up again and new wounds not closing. It can also lead to holes (called perforations) opening up in the stomach or intestine. Tell your doctor right away if you have pain in your belly or vomiting.
Because some of these drugs can affect wound healing, they usually need to be stopped before any planned surgery, including dental procedures. Talk to your cancer doctor as soon as you know about a planned surgery or other procedure so you can find out what to do.
Some drugs can damage the heart, especially if used with certain chemotherapy drugs. Your doctor may test your heart function before starting treatment. Possible symptoms of heart damage might include chest pain, increased coughing, trouble breathing (especially at night), rapid weight gain, dizziness, fainting, or swelling in the ankles or legs.
Certain targeted therapy drugs work by basically taking the brakes off the body’s immune system. This can lead to serious side effects if the immune system starts to attack healthy parts of the body. In some people this can cause serious reactions in the lungs, intestines, liver, skin, eyes, nerves, hormone-making glands, or other organs. This isn’t common but in some people it might be serious enough to be life threatening.
Some targeted therapies cause facial swelling, especially around the eyes. They can also cause swelling in the feet and legs, as well as the hands. This usually doesn’t need to be treated, but a diuretic (water pill) may be used in severe cases.
Other side effects have also been linked to treatment with some targeted therapy drugs. Many of these side effects are the same as those seen with standard chemo drugs, and include:
Your cancer care team will watch you closely during treatment and will check you often. Side effects can and should be treated as early as possible. It’s important that you tell your cancer care team about any changes in how you feel or anything you notice that’s new or unusual. Tell them right away so they can treat any problems and try to keep them from getting worse.
To learn more about any of the side effects mentioned here, see Managing Cancer-related Side Effects.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Society of Clinical Oncology (ASCO). Understanding targeted therapy. Accessed at https://www.cancer.net/navigating-cancer-care/how-cancer-treated/personalized-and-targeted-therapies/understanding-targeted-therapy on July 1, 2019.
Brown VT. Targeted therapy. In Olsen MM, LeFebvre KB, Brassil KJ, eds. Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice. Pittsburgh, PA: Oncology Nursing Society; 2019:103-139.
Mori S, Hickey A, Dusza SW, et al. Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions. J Am Acad Dermatol. 2019; 80(3):608-616.
National Cancer Institute (NCI). Targeted cancer therapies. Accessed at https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet on July 14, 2019.
Ocvirk J, Heeger S, McCloud P, Hofheinz RD. A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis. Radiol Oncol. 2013;47:166-175.
Peuvrel L, Dréno B. Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management. Am J Clin Dermatol. 2014;15:425-444.
Russo I, Zorzetto L, Chiarion Sileni Vet al. Cutaneous side effects of targeted therapy and immunotherapy for advanced melanoma. Scientifica (Cairo). 2018; 2018:5036213. Accessed at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332919/ on July 14, 2019.
Van Leeuwen MT, Luu S, Gurney H, , et al. Cardiovascular toxicity of targeted therapies for cancer: A protocol for an overview of systematic reviews. BMJ Open. 2018; 8(6):e021064. Accessed at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042572/ on July 12, 2019.
Williams LA, Ginex PK, Ebanks Jr. GL, et al. ONS Guidelines for Cancer Treatment-Related Skin Toxicity. Oncology Nursing Forum. 2020; 47(5): 539-540
Xu MJ, Johnson DE, Grandis, JR. EGFR-targeted therapies in the post-genomic era. Cancer Metastasis Rev. 2017; 36(3):463-473.
Last Revised: December 10, 2020